A group of plaintiffs who sued Johnson & Johnson‘s (NYSE:JNJ) DePuy Orthopaedics in a bellwether case over alleged defects associated with its Pinnacle metal-on-metal hips are looking for approximately $246.1 million in damages, according to recently released court documents. The damages come after a jury in Texas federal court ruled in favor of the plaintiffs, […]
Search Results for: depuy
DePuy Synthes launches Global Unite reverse fracture shoulder implant
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today announced the launch of the Global Unite reverse fracture shoulder implant designed for shoulder reconstruction procedures following complex fractures in patients with grossly deficient rotator cuffs. The newly launched system is intended to provide increased flexibility for securely reattaching the bone to the implant, which DePuy Synthes said is important […]
DePuy Synthes touts improved functionality, shorter hospital stays with Attune knee
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes late last week released new data on its Attune knee system from a study and internal report, touting potential benefits of the system. The company released data from a study of the Attune knee implant comparing it to preoperative baseline at six months. Data from the study indicated a statistically […]
J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked a deal to acquire the assets of Medical Enterprises Distribution, including its automated ME1000 surgical impactor designed for hip replacements, for an undisclosed amount. DePuy said that it expects the deal to close during the second quarter of this year, and that the deal is still subject […]
Judge limits damages to last 4 years in DePuy patent spat
A US District Judge last week capped damages in an orthopedic device patent infringement case against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes, limiting damages to the last four years. In the case, plaintiff Acantha accused DePuy of infringing on a patent with its Vector and Zero-P VA product lines. The patent was issued originally in 2001, […]
J&J’s DePuy Synthes touts anterior-approach results in comparative THA study
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today touted results from a systemic review of prospective studies comparing postoperative outcomes of both anterior and posterior approaches to total hip arthroplasty procedures. Results from the study, which were published in The Journal of Arthroplasty, indicated that the anterior approach results in increases in hip function and reduction in […]
Revision rates prompt recalls for Johnson & Johnson’s DePuy Synthes, Zimmer Biomet
High revision rates for orthopedic implants prompted recalls in recent months for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes and Zimmer Biomet (NYSE:ZBH). Last month DePuy Synthes recalled a stand-alone element of its Sigma HP partial knee replacement, the Sigma HP PFJ cemented trochlear implant, “based on elevated revision rates observed as part of the company’s post-market surveillance […]
Centinel Spine closes buyout of DePuy Synthes Prodisc assets
Centinel Spine said last week that it closed its acquisition of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets for an undisclosed amount. The deal covers DePuy’s Prodisc-C, Prodisc-L, Prodisc-C Vivo, Prodisc-C Nova, Prodisc-O and Discover cervical and lumbar artificial disc systems. The Prodisc-C and Prodisc-L are the only two products which have approval in the U.S. Centinel plans to […]
J&J’s DePuy Synthes launches Purevue visualization system
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it launched the Purevue visualization system imaging platform designed for minimally invasive endoscopic surgery. The newly launched system combines a light source, image processor and local image management, looking to reduce the equipments footprint in the operating room, DePuy said. The system also includes an autoclavable camera head, touch-screen […]
J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial
A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its Pinnacle metal-on-metal hip implants, according to a Reuters report. The jury ruled that the controversial metal-on-metal hip implants were defectively designed and that patients did not receive […]
Johnson & Johnson’s DePuy can’t stop ex-rep from working for Arthrex distributor
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes can’t stop a former sales rep from working for an Arthrex distributor in Idaho, a federal judge ruled last week. DePuy hired Richard “Jake” Williams in June 2015 to rep its orthopedic implants in Boise and had him sign employee secrecy, intellectual property, non-competition and non-solicitation agreements barring him from […]
